These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12492736)

  • 1. Pharmacokinetics of budesonide controlled ileal release capsules in children and adults with active Crohn's disease.
    Lundin PD; Edsbäcker S; Bergstrand M; Ejderhamn J; Linander H; Högberg L; Persson T; Escher JC; Lindquist B
    Aliment Pharmacol Ther; 2003 Jan; 17(1):85-92. PubMed ID: 12492736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of food on the pharmacokinetics of budesonide controlled ileal release capsules in patients with active Crohn's disease.
    Lundin P; Naber T; Nilsson M; Edsbäcker S
    Aliment Pharmacol Ther; 2001 Jan; 15(1):45-51. PubMed ID: 11136277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budesonide (Entocort EC Capsules): a review of its therapeutic use in the management of active Crohn's disease in adults.
    McKeage K; Goa KL
    Drugs; 2002; 62(15):2263-82. PubMed ID: 12381231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacoscintigraphic evaluation of oral budesonide given as controlled-release (Entocort) capsules.
    Edsbäcker S; Bengtsson B; Larsson P; Lundin P; Nilsson A; Ulmius J; Wollmer P
    Aliment Pharmacol Ther; 2003 Feb; 17(4):525-36. PubMed ID: 12622761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease.
    Edsbäcker S; Andersson T
    Clin Pharmacokinet; 2004; 43(12):803-21. PubMed ID: 15355126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States.
    Tremaine WJ; Hanauer SB; Katz S; Winston BD; Levine JG; Persson T; Persson A;
    Am J Gastroenterol; 2002 Jul; 97(7):1748-54. PubMed ID: 12135030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's disease.
    Dilger K; Alberer M; Busch A; Enninger A; Behrens R; Koletzko S; Stern M; Beckmann C; Gleiter CH
    Aliment Pharmacol Ther; 2006 Feb; 23(3):387-96. PubMed ID: 16422998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease.
    Cortot A; Colombel JF; Rutgeerts P; Lauritsen K; Malchow H; Hämling J; Winter T; Van Gossum A ; Persson T; Pettersson E
    Gut; 2001 Feb; 48(2):186-90. PubMed ID: 11156638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.
    Campieri M; Ferguson A; Doe W; Persson T; Nilsson LG
    Gut; 1997 Aug; 41(2):209-14. PubMed ID: 9301500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.
    Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E
    N Engl J Med; 1998 Aug; 339(6):370-4. PubMed ID: 9691103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pharmacokinetic Bridging Study to Compare Systemic Exposure to Budesonide between Budesonide Oral Suspension and ENTOCORT EC in Healthy Individuals.
    Song IH; Finkelman RD; Lan L
    Drugs R D; 2020 Dec; 20(4):359-367. PubMed ID: 33057953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of Crohn's disease over 12 months: fixed versus flexible dosing regimen using budesonide controlled ileal release capsules.
    Green JR; Lobo AJ; Giaffer M; Travis S; Watkins HC;
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1331-41. PubMed ID: 11552903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial.
    Escher JC;
    Eur J Gastroenterol Hepatol; 2004 Jan; 16(1):47-54. PubMed ID: 15095852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group.
    Greenberg GR; Feagan BG; Martin F; Sutherland LR; Thomson AB; Williams CN; Nilsson LG; Persson T
    N Engl J Med; 1994 Sep; 331(13):836-41. PubMed ID: 8078529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group.
    Greenberg GR; Feagan BG; Martin F; Sutherland LR; Thomson AB; Williams CN; Nilsson LG; Persson T
    Gastroenterology; 1996 Jan; 110(1):45-51. PubMed ID: 8536887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral budesonide in active Crohn's disease.
    Löfberg R; Danielsson A; Salde L
    Aliment Pharmacol Ther; 1993 Dec; 7(6):611-6. PubMed ID: 8161666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of budesonide with prednisolone for active Crohn's disease.
    Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H
    N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of oral budesonide in the treatment of active distal ulcerative colitis.
    Kolkman JJ; Möllmann HW; Möllmann AC; Penã AS; Greinwald R; Tauschel HD; Hochhaus G
    Drugs Today (Barc); 2004 Jul; 40(7):589-601. PubMed ID: 15510233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effectiveness of various budesonide preparations in Crohn disease].
    Schölmerich J
    Med Klin (Munich); 1999 Feb; 94 Suppl 1():30-8. PubMed ID: 10194946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of joint pain in Crohn's patients with budesonide controlled ileal release.
    Florin TH; Graffner H; Nilsson LG; Persson T
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):295-8. PubMed ID: 10779128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.